| 摘要 |
<p>PROBLEM TO BE SOLVED: To provide the completion version of a cancer eradication oral medicine.SOLUTION: A completion version of cancer eradication oral medicine is characterized by preparation of miR-520d which is one of microRNAs required for initializing a cancer cell mainly by a human iPS mediation, and by simplification from a conventional miR-520d venous injection to oral ingestion by coating or encapsulation to protect from gastric acid or heat. Thus, the miR-520d, which is one of the microRNAs, is digested and absorbed in intestine, and spreads hematogenously throughout the body, and completed by initializing all cells of systemic terminal cancer and returning to normal cells.</p> |
